Abstract
Treatment of Ewing sarcoma (ES) necessitates coordinated multi-disciplinary care. We analyzed outcome for 39 patients treated at a single institution in Lebanon, a developing country with available multidisciplinary treatment modalities, where financial barriers to care are overcome by a fundraising system. Median follow-up was 58 months. Five-year overall and event-free survival were 76% and 58%, respectively, for localized disease, and 40% and 38%, respectively, for metastatic disease. We conclude that, in a country with emerging economy, by following international protocols and ensuring availability of needed resources, outcome of patients with ES is similar to that in developed countries.
| Original language | English |
|---|---|
| Pages (from-to) | 1472-1475 |
| Number of pages | 4 |
| Journal | Pediatric Blood and Cancer |
| Volume | 61 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 2014 |
Keywords
- Ewing sarcoma
- Pediatric
- Prognostic factors